ImmunityBio (IBRX) Amortization - Intangibles (2015 - 2021)
ImmunityBio (IBRX) reported Amortization - Intangibles of -$23000.0 for Q2 2021, up 52.08% year-over-year from -$15123.3 in Q2 2020, and up 94.01% quarter-over-quarter from -$384000.0 in Q4 2020.
ImmunityBio (IBRX) Amortization - Intangibles (2015 - 2021) Analysis & Trends
ImmunityBio (IBRX) has 7 years of Amortization - Intangibles data on file, last reported at -$23000.0 in Q2 2021.
- Amortization - Intangibles for Q2 2021 came in at -$23000.0, up 52.08% year-over-year; the trailing twelve-month figure through Jun 2021 was -$836000.0 (down 808.7% YoY), and the FY2020 annual result was -$858000.0, down 28700.0% from the prior year.
- Amortization - Intangibles advanced to -$23000.0 in Q2 2021 per IBRX's latest filing, from -$384000.0 in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $42000.0 in Q2 2019 and troughed at -$572000.0 in Q1 2017.
- A 5-year average of -$172823.5 and a median of -$81000.0 in 2018 frame the typical range for Amortization - Intangibles.
- The sharpest annual moves came in 2019 and 2020: Amortization - Intangibles surged 133.33% in 2019, then slumped 3100.0% in 2020.
- A 5-year view of Amortization - Intangibles shows it stood at -$299000.0 in 2017, then surged by 72.91% to -$81000.0 in 2018, then surged by 85.19% to -$12000.0 in 2019, then tumbled by 3100.0% to -$384000.0 in 2020, then surged by 94.01% to -$23000.0 in 2021.
- Business Quant data shows IBRX's Amortization - Intangibles at -$23000.0 in Q2 2021, -$384000.0 in Q4 2020, and -$381000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -23,000.00 |
| Dec 31, 2020 | -384,000.00 |
| Sep 30, 2020 | -381,000.00 |
| Jun 30, 2020 | -48,000.00 |
| Mar 31, 2020 | -45,000.00 |
| Dec 31, 2019 | -12,000.00 |
| Sep 30, 2019 | 13,000.00 |
| Jun 30, 2019 | 42,000.00 |
| Mar 31, 2019 | -40,000.00 |
| Dec 31, 2018 | -81,000.00 |
| Sep 30, 2018 | -39,000.00 |
| Jun 30, 2018 | -142,000.00 |
| Mar 31, 2018 | -201,000.00 |
| Dec 31, 2017 | -299,000.00 |
| Sep 30, 2017 | -359,000.00 |
| Jun 30, 2017 | -367,000.00 |
| Mar 31, 2017 | -572,000.00 |
| Dec 31, 2016 | -615,000.00 |
| Sep 30, 2016 | -625,000.00 |
| Jun 30, 2016 | -516,000.00 |